Big pharma (+instos in the accumulation phases) have traditionally control BOTs share price a lot more than the market does.
The way I see it, believe in the product, trust the board and if you're planning on holding for ~2 years, get in asap and start accumulating (leaving some $$ aside to average down should a dip occur).
This upcoming webinar is the first mention from BOT since the approval (it's been a long two months of odd radio silence), providing a key milestone in path to sales and something that will continue holding us in this 40-50c SP.
Bot Chart, page-14444
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.8¢ | $954.2K | 2.577M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 89025 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1729 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |